Abstract P4-14-01: Trastuzumab emtansine improves overall survival versus capecitabine plus lapatinib in patients with previously treated HER2-positive advanced breast cancer: Final results from the phase 3 EMILIA studyVéronique Dièras, Lorenzo Gianni, Shivani Verma et al.|Cancer Research|2016Cited by 0